Company / Capital Expenditures
Medtronic Capital Expenditures History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.6B
FY2026
5-year range
$1.2B / $1.9B
FY2022-FY2026
Trend
+8.8%
vs FY2025
Sector context
#5 of 151
Health Care
What the data says
Among 151 Health Care companies, Medtronic is in the top 3% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $1.1B in FY2017 to $1.9B in FY2024.
Based on SEC 10-K filings.
$1.6B in FY2026 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Declined from $1.9B to $1.6B over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 151This company $1.6B Sector average $271.7M
▼
+484.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2026, capital expenditures increased 8.8% year-over-year.
- Ranks #5 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.6B | +8.8% |
| FY2025 | $1.5B | -21.5% |
| FY2024 | $1.9B | +37.2% |
| FY2023 | $1.4B | +11.7% |
| FY2022 | $1.2B | +7.0% |
| FY2021 | $1.1B | -16.3% |
| FY2020 | $1.4B | +11.7% |
| FY2019 | $1.2B | +7.0% |
| FY2018 | $1.1B | +6.2% |
| FY2017 | $1.1B | -14.8% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026